BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND TCF3, E2A, 6929, ENSG00000071564, P15923, MGC129648, MGC129647, ITF1
490 results:

  • 1. Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like lymphomas in mice.
    Bristol JA; Nelson SE; Ohashi M; Casco A; Hayes M; Ranheim EA; Pawelski AS; Singh DR; Hodson DJ; Johannsen EC; Kenney SC
    PLoS Pathog; 2024 Apr; 20(4):e1012132. PubMed ID: 38620028
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
    Wu LX; Zhao MY; Yan N; Zhou YL; Cao LM; Qin YZ; Jiang Q; Xu LP; Zhang XH; Huang XJ; Jiang H; Ruan GR
    Clin Exp Med; 2024 Mar; 24(1):56. PubMed ID: 38546916
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in
    Gutierrez-Camino A; Caron M; Richer C; Fuchs C; Illarregi U; Poncelet L; St-Onge P; Bataille AR; Tremblay-Dauphinais P; Lopez-Lopez E; Camos M; Ramirez-Orellana M; Astigarraga I; Lécuyer É; Bourque G; Martin-Guerrero I; Sinnett D
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338754
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.
    Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical Laboratory.
    Hu Z; Kovach AE; Yellapantula V; Ostrow D; Doan A; Ji J; Schmidt RJ; Gu Z; Bhojwani D; Raca G
    J Mol Diagn; 2024 Jan; 26(1):49-60. PubMed ID: 37981088
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Presence of leukemic clone-specific immunoglobulin heavy chain rearrangements in neonatal blood spots of children with B-cell precursor acute lymphoblastic leukemia.
    Kacanski N; Kolarovic J; Kostic T; Marjanovic I; Janic D; Pavlovic S; Karan-Djurasevic T
    Int J Lab Hematol; 2024 Apr; 46(2):303-311. PubMed ID: 37929321
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Clinical Significance of Minimal Residual Disease in Pediatric Patients with
    Xue YJ; Lu AD; Wang Y; Jia YP; Zuo YX; Zhang LP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1303-1308. PubMed ID: 37846676
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia.
    Gupta DG; Varma N; Abdulkadir SA; Sreedharanunni S; Sachdeva MUS; Naseem S; Bose P; Binota J; Malhotra P; Khadwal A; Trehan A; Varma S
    Cancer; 2024 Mar; 130(5):713-726. PubMed ID: 37819686
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular characterization of tcf3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment.
    Burmeister T; Gröger D; Gökbuget N; Spriewald B; Starck M; Elmaagacli A; Hoelzer D; Keller U; Schwartz S
    Sci Rep; 2023 Sep; 13(1):15167. PubMed ID: 37704696
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. BRD4 PROTAC degrader MZ1 exhibits anti-B-cell acute lymphoblastic leukemia effects via targeting CCND3.
    Ma L; Wang J; Yang Y; Lu J; Ling J; Chu X; Zhang Z; Tao Y; Li X; Tian Y; Li Z; Zhang Y; Sang X; Lu L; Wan X; Zhang K; Chen Y; Yu J; Zhuo R; Wu S; Pan J; Zhou X; Hu Y; Hu S
    Hematology; 2023 Dec; 28(1):2247253. PubMed ID: 37594294
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Leukemia Genotype Analysis of Children with Acute Lymphoblastic Leukemia in Yunnan Area].
    Shi SL; Kui LY; Xia SM; Zhou BL; Li RJ; Jiang HC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):980-984. PubMed ID: 37551465
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Transcription factor abnormalities in B-ALL leukemogenesis and treatment.
    Yin H; Wang J; Tan Y; Jiang M; Zhang H; Meng G
    Trends Cancer; 2023 Oct; 9(10):855-870. PubMed ID: 37407363
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. ZNF384-Related Fusion Genes in Acute Lymphoblastic Leukemia.
    Zhu L; Bai W; Cheng Q; Fang J
    Cancer Control; 2023; 30():10732748231182787. PubMed ID: 37306722
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Rare
    Miyamoto S; Urayama KY; Arakawa Y; Koh K; Yuza Y; Hasegawa D; Taneyama Y; Noguchi Y; Yanagimachi M; Inukai T; Ota S; Takahashi H; Keino D; Toyama D; Takita J; Tomizawa D; Morio T; Koike K; Moriwaki K; Sato Y; Fujimura J; Morita D; Sekinaka Y; Nakamura K; Sakashita K; Goto H; Manabe A; Takagi M
    Pediatr Hematol Oncol; 2024; 41(1):81-87. PubMed ID: 37129918
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Anaplastic large cell lymphomas with the 6p25.3 rearrangement are a heterogeneous group of tumours with a diverse molecular background.
    Díaz de la Pinta FJ; Rodríguez Moreno M; Salgado RN; Carvajal García N; Santonja C; Pérez Buira S; Piris MA; Requena L; Manso R; Rodríguez-Pinilla SM
    Hum Pathol; 2023 Jul; 137():71-78. PubMed ID: 37127078
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Incremental health care expenditures for non-Hodgkin lymphoma in comparison with other cancers: Analysis of national survey data.
    Zakeri M; Li J; Sansgiry SS; Aparasu RR
    J Manag Care Spec Pharm; 2023 May; 29(5):480-489. PubMed ID: 37121258
    [No Abstract]    [Full Text] [Related]  

  • 17. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
    Davis K; Sheikh T; Aggarwal N
    Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. tcf3 gene rearrangements in pediatric B-cell acute lymphoblastic leukemia-A single center experience.
    Zerkalenkova E; Menchits Y; Borkovskaia A; Sokolova S; Soldatkina O; Mikhailova E; Popov A; Komkov A; Rumiantseva Y; Karachunskii A; Olshanskaya Y
    Int J Lab Hematol; 2023 Aug; 45(4):533-540. PubMed ID: 37058324
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
    Liu Y; Klein J; Bajpai R; Dong L; Tran Q; Kolekar P; Smith JL; Ries RE; Huang BJ; Wang YC; Alonzo TA; Tian L; Mulder HL; Shaw TI; Ma J; Walsh MP; Song G; Westover T; Autry RJ; Gout AM; Wheeler DA; Wan S; Wu G; Yang JJ; Evans WE; Loh M; Easton J; Zhang J; Klco JM; Meshinchi S; Brown PA; Pruett-Miller SM; Ma X
    Nat Commun; 2023 Apr; 14(1):1739. PubMed ID: 37019972
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Mitotic recombinatory evolution in acute leukemia.
    Papenhausen P; Kelly CA; Zhang Z; Penton A
    Cancer Genet; 2023 Jun; 274-275():33-40. PubMed ID: 36966725
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 25.